Relationship Between Plasma Aldosterone Concentrations and Non-Alcoholic Fatty Liver Disease Diagnosis in Patients with Hypertension: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Relationship Between Plasma Aldosterone Concentrations and Non-Alcoholic Fatty Liver Disease Diagnosis in Patients with Hypertension: A Retrospective Cohort Study

Published:2023-06 Issue: Volume:Volume 16 Page:1625-1636
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity
language:en
Short-container-title:DMSO

Author:

Hu Junli,Cai Xintian^ORCID,Zhu Qing,Heizhati Mulalibieke,Wen Wen^ORCID,Luo Qin,Hong Jing,Dang Yujie,Yang Wenbo,Li Nanfang

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference56 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

3. Epidemiological Features of NAFLD From 1999 to 2018 in China

4. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

5. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study;Frontiers in Endocrinology;2024-08-20

2. Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults;Scientific Reports;2024-08-09

3. Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout;Frontiers in Endocrinology;2024-07-30

4. Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis;Endokrynologia Polska;2024-06-26

5. Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients;Drug Design, Development and Therapy;2024-06